Active Ingredient History
An essential amino acid, or indispensable amino acid, is an amino acid that cannot be synthesized from scratch by the organism fast enough to supply its demand, and must therefore come from the diet. Of the 21 amino acids common to all life forms, the nine amino acids humans cannot synthesize are phenylalanine, valine, threonine, tryptophan, methionine, leucine, isoleucine, lysine, and histidine. Wikipedia
Combination drugs
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Aging (Phase 1)
Anemia (Phase 2/Phase 3)
Atrophy (Phase 4)
Breast Neoplasms (Phase 2)
Child Development (Phase 4)
Colorectal Neoplasms (Phase 4)
COVID-19 (Phase 2/Phase 3)
Critical Illness (Phase 4)
Cystectomy (Phase 4)
Dental Plaque (Phase 3)
Dermatitis, Atopic (Phase 3)
Dialysis (Phase 4)
Diarrhea (Phase 4)
Diet, Protein-Restricted (Phase 4)
Eczema (Phase 3)
Enteral Nutrition (Phase 4)
Fatigue Syndrome, Chronic (Phase 1)
Femur Head Necrosis (Phase 2)
Geriatrics (Phase 4)
Growth and Development (Phase 3)
Healthy Volunteers (Phase 1)
Hip Fractures (Phase 2)
HIV Infections (Phase 3)
Infections (Phase 4)
Inflammation (Phase 4)
Iron Deficiencies (Phase 4)
Kidney Diseases (Phase 2)
Kidney Failure, Chronic (Phase 1)
Kwashiorkor (Phase 1)
Lung Diseases (Phase 2)
Malnutrition (Phase 2)
Medulloblastoma (Phase 2)
Meningioma (Phase 2)
Metabolic Diseases (Phase 1)
Milk Hypersensitivity (Phase 3)
Multiple Organ Failure (Phase 4)
Muscles (Phase 4)
Muscular Atrophy (Phase 2)
Neoplasms (Phase 4)
Nervous System Diseases (Phase 3)
Neuroblastoma (Phase 2)
Neuroendocrine Tumors (Phase 3)
Non-alcoholic Fatty Liver Disease (Phase 2)
Osteoarthritis (Phase 2)
Paraganglioma (Phase 2)
Phenylketonurias (Phase 4)
Pheochromocytoma (Phase 2)
Postural Balance (Phase 3)
Pregnancy Complications (Phase 1)
Premature Birth (Phase 4)
Protein-Energy Malnutrition (Phase 1)
Quality of Life (Phase 2)
Renal Insufficiency (Phase 2)
Respiratory Tract Infections (Phase 4)
Sarcopenia (Phase 1)
Survival (Phase 4)
Thoracic Surgery (Phase 3)
Tissue Adhesions (Phase 1)
Triple Negative Breast Neoplasms (Phase 2)
Uremia (Phase 4)
Urinary Bladder Neoplasms (Phase 4)
Urinary Tract Infections (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue